n.a. (CVD)

106.42
NYSE
Prev Close 106.42
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)
Covance Management Discusses Q2 2012 Results - Earnings Call Transcript

Covance Management Discusses Q2 2012 Results - Earnings Call Transcript

Covance Management Discusses Q2 2012 Results - Earnings Call Transcript

Upgrades Roundup: Lincoln National, Forest Oil

Upgrades Roundup: Lincoln National, Forest Oil

These stocks received upgrades from TheStreet Ratings last week.

Covance Inc. Stock Upgraded (CVD)

Covance Inc. Stock Upgraded (CVD)

Covance (NYSE:CVD) has been upgraded by TheStreet Ratings from a hold to buy.

Covance's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Covance's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Covance's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Charting Bonds and Biotech

Charting Bonds and Biotech

TLT is testing its 200-day moving average, and I have an actionable channel trade on CVD.

Covance Rises On Unusually High Volume (CVD)

Covance Rises On Unusually High Volume (CVD)

Covance (NYSE:CVD) is trading at unusually high volume Wednesday with 2.3 million shares changing hands. It is currently at four times its average daily volume and trading up $1.19 (+2.7%).

Covance's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Covance Stock Hits New 52-Week Low (CVD)

Covance Stock Hits New 52-Week Low (CVD)

Covance (NYSE:CVD) hit a new 52-week low Thursday as it is currently trading at $42.73, below its previous 52-week low of $42.79 with 1.2 million shares traded as of 9:55 a.m. ET. Average volume has been 575,100 shares over the past 30 days.

Analysts' Actions: BA, MCD, HES, NFLX, DAL

Analysts' Actions: BA, MCD, HES, NFLX, DAL

Here are today's top research calls.

Covance's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Covance Inc. (CVD): Today's Featured Health Care Loser

Covance Inc. (CVD): Today's Featured Health Care Loser

Covance Inc was a leading decliner within the health care sector, falling $1.98 (-3.9%) to $48.75 on average volume.

8 Health Care Buys Ahead of Earnings

8 Health Care Buys Ahead of Earnings

Analysts think these eight stocks to have a healthy upside, and all are scheduled to release quarterly earnings next week.

Covance Stock Hits New 52-Week Low (CVD)

Covance Stock Hits New 52-Week Low (CVD)

Covance (NYSE:CVD) hit a new 52-week low Tuesday as it is currently trading at $42.82, below its previous 52-week low of $43 with 34,930 shares traded as of 10:05 a.m. ET. Average volume has been 735,800 shares over the past 30 days.

Covance Inc. Stock Downgraded (CVD)

Covance Inc. Stock Downgraded (CVD)

Covance (NYSE:CVD) has been downgraded by TheStreet Ratings from from a buy to hold.

'Fast Money' Recap: Gold Isn't a Bubble

'Fast Money' Recap: Gold Isn't a Bubble

Dennis Gartman told the trading panel that gold hadn't reached the bubble stage.

Covance's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Covance Inc. Stock Upgraded (CVD)

Covance Inc. Stock Upgraded (CVD)

Covance (NYSE:CVD) has been upgraded by TheStreet Ratings from a hold to buy.

Covance's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Covance Stock Hits New 52-Week High (CVD)

Covance Stock Hits New 52-Week High (CVD)

Covance (NYSE:CVD) hit a new 52-week high Thursday as it is currently trading at $62.16, above its previous 52-week high of $62.15 with 184,790 shares traded as of 11:56 a.m. ET. Average volume has been 665,500 shares over the past 30 days.

Covance CEO Discusses Q4 2010 Earnings Call Transcript

Covance CEO Discusses Q4 2010 Earnings Call Transcript

Covance CEO Discusses Q4 2010 Earnings Call Transcript

Covance Q3 2010 Earnings Call Transcript

Covance Q3 2010 Earnings Call Transcript

Covance Inc. Q2 2010 Earnings Call Transcript

Covance Inc. Q2 2010 Earnings Call Transcript

Covance Inc. Q2 2010 Earnings Call Transcript

Apollo Group - Upgrades & Downgrades

TheStreet Ratings released rating changes on 10 U.S. common stocks for June 25, 2010. Five stocks have been downgraded and five stocks have been upgraded by our stock model.

What to Watch on Apple's Chart Today

As Apple opens its World Wide Developer Conference, we can see two levels on its chart that are important to keep in view as the stock trades.

Covance Inc. Q1 2010 Earnings Call Transcript

Covance Inc. Q1 2010 Earnings Call Transcript

Debt-Free Short-Squeeze Opportunities

Debt-Free Short-Squeeze Opportunities

These heavily shorted stocks, including Garmin, could surge higher on any positive catalyst.

Biotech Built for Life: Under the Radar

Biotech Built for Life: Under the Radar

Techne profits from success and failure. It sells the proteins and antibodies that biotech companies and academics explore.

Earnings Roundup: Wells Fargo, EBay

Earnings Roundup: Wells Fargo, EBay

Earnings roundup: Wells Fargo 3Q profit rises, eBay 3Q net income down though revenue rose

Covance 3Q Profit Remains Flat

Covance 3Q Profit Remains Flat

Covance's 3rd-quarter profit remains flat as higher expenses offset revenue boost

Premarket Roundup: Corp. Executive Board, Covance

Premarket Roundup: Corp. Executive Board, Covance

Premarket roundup: Corporate Executive Board upgraded, shares jump; Covance gets rating hike